Schrödinger

Computational drug discovery platform combining physics-based simulation and molecular modeling.

Open source: No

Editorial review

Schrödinger has not yet been editorially reviewed. User reviews and published field data below are unaffected — we say so rather than implying an editorial verdict.

Facts & attributes

Every value carries its evidence state. “—” means unknown — never a silent default (P-02).

Identity · Taxonomy

Tags(open-source;cloud-native): computational chemistry, drug discovery, molecular modeling, materials science, physics-based simulationVerification pending

Features · Product · Fit

Core capabilities(authoring;automation;analytics): Physics-based computational platform for molecular discovery, Molecular dynamics simulations (Desmond), Free energy calculations for lead optimization (FEP+), Structure prediction and target enablement, De novo design inside Bunsen, the agentic co-scientist, Materials science modeling (MS Maestro, Jaguar)Verification pending

Api · Integrations · Ecosystem

API available(true/false): trueVerification pending

Audience · Use · Case

Best for(Neutral editorial summary): Pharma, biotech and materials teams running physics-based molecular modeling and simulationVerification pending
Primary use cases(build;monitor;automate): Small molecule drug discovery, Biologics and antibody design, Materials science R&D, Drug formulationVerification pending
Skill level(beginner;intermediate;advanced;specialist): specialistVerification pending

Vendor · Maintainer

Founded year(2012): 1990Verified
Headquarters country(US): United StatesVerified
Vendor type(commercial;foundation;community;government;consortium;individual): commercialVerification pending

Also categorized in

Molecular Modeling Software

User reviews

Review policy

No published reviews yet.